Abstract

The exercise paradox infers that, despite the well‐established cardioprotective effects of repeated episodic exercise (training), the risk of acute atherothrombotic events may be transiently increased during and soon after an exercise bout. However, the acute impact of different exercise modalities on platelet function has not previously been addressed. We hypothesized that distinct modalities of exercise would have differing effects on in vivo platelet activation and reactivity to agonists which induce monocyte‐platelet aggregate (MPA) formation. Eight middle‐aged (53.5 ± 1.6 years) male participants took part in four 30 min experimental interventions (aerobic AE, resistance RE, combined aerobic/resistance exercise CARE, or no‐exercise NE), in random order. Blood samples were collected before, immediately after, and 1 h after each intervention, and incubated with one of three agonists of physiologically/clinically relevant pathways of platelet activation (thrombin receptor activating peptide‐6 TRAP, arachidonic acid AA, and cross‐linked collagen‐related peptide xCRP). In the presence of AA, TRAP, and xCRP, both RE and CARE evoked increases in MPAs immediately post‐exercise (P < 0.01), whereas only AA significantly increased MPAs immediately after AE (P < 0.01). These increases in platelet activation post‐exercise were transient, as responses approached pre‐exercise levels by 1 h. These are the first data to suggest that exercise involving a resistance component in humans may transiently increase platelet‐mediated thrombotic risk more than aerobic modalities.

Highlights

  • Monocyte-platelet aggregates (MPAs) result from the interaction between activated platelets and monocytes

  • Our aim was to compare the impacts of distinct forms of exercise on platelet function in overweight and physically inactive men

  • This is the first study to our knowledge in humans that has directly compared the acute impacts of routinely prescribed (Garber et al 2011; Kang and Ratamess 2014) exercise modalities on monocyte-platelet aggregation in the presence agonists of physiologically/clinically relevant pathways of platelet activation

Read more

Summary

Introduction

Monocyte-platelet aggregates (MPAs) result from the interaction between activated platelets and monocytes. Platelets become activated as a consequence of exposure to various in vivo agonists including thrombin, collagen, and the arachidonic acid (AA) by-product thromboxane A2. Each of these physiological agonists targets a different platelet surface receptor and activates platelets via a 2016 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call